Everything below concerns Reverse-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-23. Numbers and descriptions here follow the published literature rather than marketing material.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
=== Tourne === Compared to malic and citric acids, tartaric acid is usually considered microbiologically stable. However, some species of Lactobacillus (particularly L. brevis and L. plantarum) have the potential to degrade tartaric acid in wine, reducing a wine's total acidity by 3-50%. French winemakers had long observed this phenomenon and called it tourne (meaning "turn to brown") in reference to the color change that can occur in the wine at the same time likely due to other processes at work in addition to the tartaric loss. While Lactobacillus is the most common culprit of tourne, some species of the spoilage film yeast Candida can also metabolize tartaric acid.
The fifth and final single from the album, "Zzyzx Rd.", started receiving radio airplay in fall 2007; no music video was made for the single. The band began touring in support of the album before its release, starting with several free shows in the US, followed by appearances at festivals in Europe. They then joined Korn for their 2006 edition of Family Values Tour across the US, with 33 dates across 3 months. On August 8, 2006, Stone Sour made a special guest appearance on The Tonight Show with Jay Leno to promote and perform the second single, "Through Glass." They also performed at the Japanese Summer Sonic Festival midway through the Family Values Tour. In November and December 2006, Stone Sour joined Disturbed for their Music as a Weapon Tour. In January 2007, Stone Sour joined Evanescence for a Canadian tour, followed by a headlining tour of Europe. They then headlined the spring 2007 Jägermeister Music Tour across the US, followed by headlining tours in Australia and Japan. They then started a tour in Europe playing at festivals and selected headline shows. They finished touring in support of the album with a headlining tour in the US in August and September in 2007.
These 35 are known as primordial radionuclides. Well-known examples are uranium and thorium, but also included are naturally occurring long-lived radioisotopes, such as potassium-40. Each of the heavy primordial radionuclides participates in one of the four decay chains.
2 HO–CH2CH2–Cl + Ca(OH)2 → 2 (CH2CH2)O + CaCl2 + 2H2O The produced ethylene oxide is purified by distillation. The chlorohydrin process allows to reach 95% conversion of ethylene chlorohydrin. The yield of ethylene oxide is about 80% of the theoretical value; for 1 tonne (0.98 long tons; 1.1 short tons) of ethylene oxide, about 200 kg (440 lb) of ethylene dichloride is produced. But, the major drawbacks of this process are high chlorine consumption and effluent load. This process is now obsolete.
== External links == The MEROPS online database for peptidases and their inhibitors: Pepsin A A01.001 Archived 2008-03-20 at the Wayback Machine, Pepsin B A01.002 Archived 2007-12-21 at the Wayback Machine, Pepsin C (Gastricsin) A01.003 Archived 2020-06-02 at the Wayback Machine Pepsin+A at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogens at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogen+A at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogen+C at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Beemans Gum Pepsin: Molecule of the Month Archived 2015-11-30 at the Wayback Machine, by David Goodsell, RCSB Protein Data Bank Overview of all the structural information available in the PDB for UniProt: P20142 (Human Gastricsin) at the PDBe-KB. Overview of all the structural information available in the PDB for UniProt: P0DJD7 (Pepsin A-4) at the PDBe-KB.
Sources: en.wikipedia.org
=== Non-tuberculous mycobacteria === Isoniazid may also be used off-label to treat nontuberculous mycobacterial pulmonary disease. Isoniazid was widely used in the treatment of Mycobacterium avium complex as part of a regimen including rifampicin and ethambutol. Evidence suggests that isoniazid prevents mycolic acid synthesis in M. avium complex as in M. tuberculosis and although this is not bactericidal to M. avium complex, it greatly potentiates the effect of rifampicin.
Sauropsida/ Reptilia sensu lato †Araeoscelidia? †Parareptilia (polyphyletic) Diapsida/Neodiapsida †Drepanosauromorpha (placement uncertain) †Younginiformes (likely paraphyletic) †Ichthyosauromorpha (placement uncertain) †Thalattosauria (placement uncertain) †Sauropterygia (placement uncertain) †Choristodera (placement uncertain) †Kuehneosauridae (placement uncertain) Sauria/ Reptilia sensu stricto Lepidosauromorpha Lepidosauria Rhynchocephalia (tuatara) Squamata (lizards and snakes) Pantestudines (turtles and kin, placement uncertain) Archosauromorpha †Protorosauria (paraphyletic) †Rhynchosauria †Allokotosauria Archosauriformes †Phytosauria Archosauria Pseudosuchia Crocodilia (crocodilians) Avemetatarsalia/Ornithodira †Pterosauria Dinosauria †Ornithischia Saurischia (including birds (Aves))
Full-fat soybean meal, made from whole soybeans. It has a high metabolizable energy concentration. (For example, metabolizable energy for swine in this product is about 3.69 megacalories (i.e. 15.4 MJ) per kg dry matter.) Crude protein concentration is about 38 percent (as fed). This kind of product is sometimes fed to various classes of livestock. Defatted soybean meal, containing no hulls. This product has an intermediate energy concentration. (For example, Balaji metabolizable energy for swine in this product is about 3.38 megacalories (i.e. 14.1 MJ) per kg dry matter.) Crude protein concentration is about 48 percent. This percentage [which is commonly used in describing the product] is calculated at the typical as-fed moisture content of 88 percent. Thus, crude protein concentration expressed on a dry matter basis is 54 percent. This product is commonly fed to swine, broilers and layers. Defatted soybean meal, containing soybean hulls. The hulls are readily digestible by ruminant livestock. This product is often fed as a protein supplement for domestic ruminants. Ruminant-metabolizable energy concentration is about 3.0 megacalories (i.e. about 12.5 MJ) per kg dry matter, and crude protein concentration is about 44 percent. The latter percentage [which is commonly used in describing the product] is calculated at the typical as-fed moisture content of 90 percent. Thus, crude protein concentration on a dry matter basis is 49 percent.
In a positive review in The New York Times, Jennifer Senior wrote that Vance's confrontation of a social taboo was admirable, regardless of whether the reader agreed with his conclusions. She described the book as "a compassionate, discerning sociological analysis of the white underclass that has helped drive the politics of rebellion, particularly the ascent of Donald J. Trump." Senior wrote that Vance's subject is despair, and his argument was more generous in that it blames fatalism and learned helplessness rather than indolence. A 2017 Brookings Institution report noted that "J. D. Vance's Hillbilly Elegy became a national bestseller for its raw, emotional portrait of growing up in and eventually out of a poor rural community riddled by drug addiction and instability." Vance's account anecdotally confirmed the report's conclusion that family stability is essential to upward mobility. In an interview with Süddeutsche Zeitung in July 2023, German chancellor Olaf Scholz called the book "a very touching personal story of how a young man with poor starting conditions makes his way." Scholz said the book had moved him to tears, but that he found the positions Vance later took to be "tragic." The book was positively received by conservatives such as National Review columnist Mona Charen and National Review editor and Slate columnist Reihan Salam. American Conservative contributor and blogger Rod Dreher expressed admiration for Hillbilly Elegy, saying that Vance "draws conclusions... that may be hard for some people to take. Vance has earned the right to make those judgments.
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.